Judy Payne Hughes, L.P.C. ; RN Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 2542 Route 66, #303, Chatham, NY 12037 Phone: 703-505-3721 |
Viola Silvan, LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 160 Loomis Rd, Chatham, NY 12037 Phone: 518-821-0793 |
Adam O'brien, LMHC CASAC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 160 Loomis Rd, Chatham, NY 12037 Phone: 518-573-2925 |
News Archive
Researchers in Canada have conducted a study suggesting that the majority of patients living with long COVID (coronavirus disease) following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) experience chronic fatigue that is at least as severe as that seen in several other clinical conditions.
The New Zealand's Ministry of Health has confirmed, as a whooping cough epidemic continues to sweep the country, that a new vaccine to control the spread of whooping cough may be introduced next year.
Researchers at Case Western Reserve University School of Medicine have identified a genetic factor that prevents blockages from forming in blood vessels, a discovery that could lead to new therapies for cardiovascular diseases.
IVAX Diagnostics, Inc., a fully integrated global in vitro diagnostics company, announced that Diamedix Corporation has signed a distribution agreement with Fumouze Diagnostics, a division of Sofibel S.A.S., of Paris, France, pursuant to which Fumouze Diagnostics will be the exclusive third party distributor of Diamedix Corporation and Delta Biologicals S.r.l.'s suite of diagnostic tests in France. Diamedix is a U.S. subsidiary of IVAX Diagnostics and Delta Biologicals is IVAX Diagnostics' subsidiary located in Italy. The initial term of the distribution agreement is three years.
› Verified 2 days ago